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Özet
Amaç: hemodializ için açılan snuff-box fistüllerden sonra ikincil arteriove-
noz fistüllerinin sonuçlarinı araştırmak. Gereç ve Yöntem: Merkezimizde ocak 
2007 ile Aralık 2015 tarihleri arasında açılan snuff box arteriovenoz fistül 
sonrası ikincil 95 AVF geriye dönük olarak değerlendirildi. Bu hastaların ta-
mamına  snuff box AVF sonrası ikincil olarak  58’ine (%61) dirsek düzeyin-
de brakio-sefalik AVF, geriye kalan 37 (%39) hastaya ise  radiyo-sefalik AVF 
açıldı. Bulgular: Tüm AVF postop erken dönemde çalıştı. Primer  açıklık oran-
ları bir yıllık  brakiosefalik AVF’de %88   iken radio-sefalik AVF’de %87 , dört 
yıllık açıklık oranları ise brakiosefalik AVF’de %70   iken radio-sefalik AVF’de 
%61  oranındaydı.  Sekonder açıklık oranları ise bir yıllık  brakiosefalik AVF’de 
%91   iken radio-sefalik AVF’de %93 , dört yıllık açıklık oranları ise brakiose-
falik AVF’de %71   iken radio-sefalik AVF’de %63  oranındaydı. Erken dönem-
de herhangi bir komplikasyon olmadı. 15 hastada ise  geç dönemde AVF dur-
du. Başarısızlığın en sık nedeni 8 hastada stenoz 5 hastada anevrizma, 2 has-
tada ise santral ven stenozu idi. Tartışma: Bu veriler ışıgında radyal-sefalik 
veya brakiosefalik arteriyovenöz fistül  oluşturulmadan önce, snuff box fistül 
açılması   damarların gelişmesini sağlamaktadır ve ikincil açılacak AVF’lerin 
başarı şansını artıracağını düşünmekteyiz. Bu nedenle radyal-sefalik arteri-
yovenöz fistül veya brakiyal-sefalik arteriyovenöz fistüller  ikincil  Olarak ter-
cih edilmelidir. 
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Abstract
Aim: To investigate the secondary arteriovenous fistulas constructed after 
a snuff-box fistula. Material and Method: We reviewed data on 95 arterio-
venous fistulas that were created as a secondary vascular access between 
January 2007 and December 2015. Of those 95 fistulas, 37 (39%) were ip-
silateral elbow brachial-cephalic arteriovenous fistulas and 58 (61%) were 
ipsilateral wrist radial-cephalic arteriovenous fistulas; all were created after 
a primary snuff-box fistula. Results: All arteriovenous fistulas had matured. 
The primary patency rates for elbow brachial-cephalic arteriovenous fistulas 
and radial-cephalic arteriovenous fistulas were as follows: 1-year rate, 88% 
to 87% and 4-year rate, 70% to 61%. The secondary patency rates for were 
as follows: 1-year rate, 91% to 93%; 4-year rate, 72% to 63%. No early 
failure occurred. There were 15 late failures. The most common causes of 
failure were stenosis within the vein (n=8 patients), aneurysm (n=5 patients), 
and central vein stenosis (n=2 patients). Discussion: These data suggest that 
before a radial-cephalic or brachial-cephalic arteriovenous fistula is cre-
ated, the construction of a snuff-box fistula enable the vascular structures 
to dilate, and may so fascilitate the success rate of seconder AVFs. For this 
reason a radial-cephalic arteriovenous fistula or an elbow brachial-cephalic 
arteriovenous fistula should be the second choice
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Introduction
The original and recently updated national kidney foundation 
dialysis outcomes quality initiative practice guidelines (NKF-
DOQI) recommend to increase the placement of native arte-
riovenous fistulas (AVFs) for the first choice of vascular access 
for hemodialysis. These guidelines also recommend that the 
order of preference for AVF creation should be the wrist radial-
cephalic (RC) type as the primary AVF and then the elbow bra-
chial-cephalic (BC) type as the secondary AVF. If either of these 
is not viable, then another type of fistula made of synthetic 
material should be used. The RC type of AVF is recommended 
as the primary and best option for vascular access[1].
The first AVF should be created as distally as possible to provide 
a long segment of arterialized vein for repeated venipuncture 
and to save alternative sites for creation of additional fistulas. 
Distal AVFs have the lowest complication rates[2,5].  A radial-
cephalic AVF in the anatomical snuff-box is the other alternative 
to a wrist RC AVF, and the most distal site of the forearm has 
been recommended by several authors as the primary option 
for an AVF.[2-5]The main advantage of the snuff-box AVF is that 
preserving the proximal vessels to create additional AVFs also 
provides a long segment of vein for needling. In case of failure 
of a snuff-box AVF after maturation, creation of a secondary 
arteriovenous access site is often facilitated by the presence of 
an already arterialized vein[5,6].
It has been informally suggested that creating a snuff-box AVF 
before an RC or a BC AVF may dilate the veins of the fore-
arm and upper arm and improve the outcome of subsequent 
AVF construction in the ipsilateral arm. That this suggestion? 
suggestion has never been systematically studied, and little is 
known or has been published about it[6].  
The aims of this retrospective study were to investigate the 
types of fistulas and the patency, maturation rates, complica-
tions, and late results of ipsilateral AVFs created after a snuff-
box fistula. 
Material and Method
Between January 2007 and December 2015, 323 snuff-box AVFs 
for hemodialysis were created at our institution. Sufficient data 
were was available for 75 patients (95 fistulas) with secondary 
AVFs created after primary functional snuff-box fistulas. When 
a snuff-box AVF failed, a standard ipsilateral RC AVF was con-
structed if possible, or a contralateral snuff-box AVF or a con-
tralateral wrist access was created. If the contralateral wrist 
was not suitable for both a snuff-box and an RC AVF, then an ip-
silateral BC AVF was created in the same extremity. All fistulas 
in this study were secondary ipsilateral RC AVFs (n=58) or BC 
AVFs (n=37). Moving to the contralateral extremity for creation 
of the secondary vascular access was the exclusion criterion. 
All AVFs were constructed with the same surgical technique by 
general surgeons experienced in vascular access. Thirty-seven 
ipsilateral BC AVFs and 58 ipsilateral RC AVFs were created 
after 95 primary snuff-box fistulas. 
Fistula patency and maturation time were obtained from dialy-
sis unit and hospital medical records. 
Demographic factors and comorbid conditions (the duration of 
treatment with hemodialysis; and the frequency of hemodialy-
sis) were also assessed. The time until fistula failure occurred 
was determined from dialysis unit notes. 
Before the operation, the adequacy of the cephalic vein and the 
arterial supply of the upper limb (brachial, radial, ulnar pulses) 
were determined by clinical examination. All secondary ac-
cesses were created under local anesthesia. All operations were 
performed as outpatient procedures.
A palpable thrill or a bruit on auscultation was taken as an in-
dicator of good fistular function. Primary failure was defined 
as those fistulas that failed within 6 weeks, before the fistula
could be used for hemodialysis, including those that were tech-
nical failures. Primary patency refers to the duration of access 
patency until the first intervention to maintain patency or until 
fistula failure. Cumulative secondary patency refers to fistulas 
functioning for dialysis, regardless of the number of interven-
tions required to maintain patency. Fistula failure was defined 
as an inability to use the fistula for hemodialysis owing to a 
cause other than transplant or death. Operative ligations were 
classified as failures. Patients who underwent renal transplant 
were considered as lost to follow-up, not as failures. Deaths 
being unrelated to fistula failure also were treated as lost to 
follow-up. A fistula was considered to have matured when it 
provided adequate dialysis. Complication rates refer to fistula-
related problems only and include the causes of fistula failure.
The mean ± SD was the descriptive statistic used to express re-
sults for quantitative variables. A Kaplan-Meier survival analy-
sis was performed according to primary and secondary patency 
rates. Differences in patency rates between RC and BC AVFs 
were assessed using the log-rank test. A p value <0.005 was 
considered statistically significant for all comparisons. 
Results
Seventy-five patients underwent the creation of a total of 95 
snuff-box fistulas. Demographic data are listed in Table I. The 
most common cause of renal failure was diabetes in 32 pa-
tients (42% of total). The other causes of renal failure were 
hypertension in 18 (24%), glomerulonephritis in 12 (16%), un-
known etiology in 7 (9%), and chronic pyelonephritis 6 (8%).
Of those 95 secondary AVFs, 37 (39%) were ipsilateral BC AVFs 
and 58 (61%) were ipsilateral RC AVFs. Forty-five RC AVFs 
(77%) and 30 BC AVFs (81%) were placed on the left side. 
Thirty-seven BC AVFs were constructed after a primary snuff-
box AVF. The reasons for creating the BC AVFs were, exten-
sive thrombosis in 20 patients (54%), stenosis (needle sites) of 
Table 1. Demographic factors and comorbid diseases of the study subjects.
Age (years, mean ± SD) 50 ± 17 (range, 18-84)
Mean time on hemodialysis (years, mean ± SD) 8 ± 3 (range, 1-20)
Fistula type (RC/BC) 93/59
Gender (male/female) 51/85
Hemodialysis frequency (d/wk) 9 (2 d/wk), 66 (3d/wk)
Side (left/right) 102/50
Diabetes mellitus 68 (50%)
Hypertension 30 (22)
Glomerulonephritis 25(18%)
Chronic pyelonephritis 6 (4%)
Unknown 7 (5%)
Journal of Clinical and Analytical Medicine  | 191
Secondary Vascular Access Procedures for Hemodialysis
 | Journal of Clinical and Analytical Medicine
Secondary Vascular Access Procedures for Hemodialysis
3
forearm cephalic outflow vein in 9 patients (24%), aneurysm 
formation of forearm cephalic outflow vein in 8 patients (21%). 
Those complications changed the operative plan to creation of 
a BC AVF. In 37 BC AVFs created at our institution, extensive 
disease within the outflow vein was the main cause of BC AVFs 
procedures. 
Maturation and complications
There were no primary failures among 95 secondary access 
procedures. The median follow-up for the patients studied was 
50 months (range, 3-65 months). All of the AVFs matured, and 
the median maturation time was 19.5 ± 3.2 days (range, 15-
30 days) for RC AVFs and 19.4 ± 2.9 days (range, 15-30 days) 
for BC AVFs. All of the secondary accesses were matured and 
functional. 
Postoperative complications included 2 infections (none of 
which required drainage) that were treated with antibiotics, and 
4 hematomas (none of which required drainage). One patient 
presented with minimal “steal” symptoms after a left-sided 
RC fistula operation. Those symptoms resolved spontaneously 
within 1 week of their onset. The overall morbidity rate was 
6%, and no patient died during the 30 days after the procedure.
Patency
Figures 1 and 2 show the primary and secondary patency rates 
determined with the Kaplan-Meier survival analysis for RC AVFs 
and BC AVFs. The primary patency rates for BC AVFs and RC 
AVFs were as follows: 1-year rate, 91% to 89%; 2-year rate, 
82% to 74%; 3-year rate, 65% to 67%; and 4-year rate, 60% to 
62%. The difference in primary patency between the 2 groups 
was not significant (p=0.9, log rank). The secondary patency 
rates for BC AVFs and RC AVFs were as follows: 1-year rate, 
96% to 93%; 2-year rate, 90% to 83%; 3-year rate, 83% to 
73%; and 4-year rate, 76% to 62%. The difference in second-
ary patency between the 2 groups was not significant (p=0.4, 
log rank). 
There were 12 late failures among 95 functional AVFs. The 
most common cause of failure was stenosis within the vein in 9 
patients (9.4%) (6 RC AVFs and 3 BC AVFs) and an aneurysm in 
3 patients (3%) (2 RC AVFs and 1 BC AVF). 
Secondary patency (successful recanalization) was attempted 
in 22 fistulas (11 RCs and 11 BCs) and was successful in the 15 
AVFs (68%) (6 RC and 9BC). Of these thrombectomies, 13 were 
surgical and 9 were performed via interventional radiology. 
Subclavian vein stenoses, which were confirmed by venograph-
ic studies, developed in 4 patients. We attempted to correct 
the stenoses with percutaneous transluminal angioplasty, but 
the interventions were unsuccessful because 2 of the stenoses 
were not elastic. 
Discussion
The number of patients worldwide with end-stage renal disease 
receiving hemodialysis treatment increases every year[7].   By 
2001, more than 1 million patients were undergoing dialysis, 
and the annual global average rate of increase was 7%[7,8].   In 
Europe, 80% of hemodialysis patients have an autogenous AVF 
as a vascular access, but only 24% of patients in the United 
States have an autogenous AVF[9].  According to the Turkish 
Nephrology Society Registry, which records data for 25 321 pa-
tients at 388 hemodialysis centers in Turkey, of patients who 
had started hemodialysis treatment for the first time, 35.6% 
have an autogenous AVF as the first intravenous route in; and 
in individuals treated with regular hemodialysis, 90.1% have an 
autogenous AVF[10].  Of those AVFs, 42% were localized 1/3 
distal region of the forearm, 25% were localized 1/3 mid region 
of the forearm and 8.5% had a snuff-box AVF[10].  .
The NKF-K/DOQI clinical practice guidelines for vascular access 
suggest placement of an autogenous AVF for primary vascular 
Figure 2. Secondary survival analysis (Kaplan-Meier) for patency of radial-cephal-
ic arteriovenous fistulas and brachial-cephalic arteriovenous fistulas in the study 
subjects. (Abbreviation; RC: radial-cephalic arteriovenous fistula; BC: brachial-
cephalic arteriovenous fistula)
Figure 1. Primary survival analysis (Kaplan-Meier) for patency of wrist radial-
cephalic arteriovenous fistulas and elbow brachial-cephalic arteriovenous fistulas 
in the study subjects. (Abbreviation; RC: radial-cephalic arteriovenous fistula; BC: 
brachial-cephalic arteriovenous fistula)
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access for hemodialysis[1]. An autogenous RC AVF is regarded 
as the first and best choice for vascular access. In our study, all 
secondary fistulas were native after the initial snuff-box AVF, 
which led to a reduction in the number of more complicated 
secondary access procedures such as AV prosthetic grafts.
The present study shows that 58 RC AVFs (61%) and 37 BC 
AVFs (39%) were feasible after primary snuff-box AVFs. Multi-
ple stenoses may develop at the site of multiple venipunctures. 
Stenosis and aneurysm formation at the inflow vein can lead 
to thrombosis. Multiple stenotic areas are associated with un-
successful thrombectomy and the need for additional BC AVFs 
instead of RC AVFs. There was no immediate failure and all 
AVFs were functional after 30 days. These 2 types of second-
ary vascular access procedures that were made after a primary 
snuff-box AVF were successful.   
“Failure to mature” is defined as the inability to use a fistula for 
hemodialysis at 6 weeks after its construction[11].  However, 
10% to 24% of RC AVFs are either compromised by a thrombo-
sis directly after surgery or do not function adequately because 
of a failure to mature[12,16].   RC AVFs have a reported matu-
ration rate of 25% to 80%[17]. Rao and colleagues reported 
that failure to mature was as high as 38%, although most other 
authors have not reported such high rates as this[18]. In our 
report, maturation rates and times were better than those cited 
in the literature[11].  Arterialized vein segments resulted in bet-
ter maturation rates and shorter maturation times. However, 
the study group was young and the mean hemodialysis time 
was short, these factors could influence the maturation rate.
A review of the literature showed that the primary patency rate 
of RC AVFs ranges from 70% to 91% at 1 year, although a recent 
meta-analysis reported that the primary patency rate may be 
as low as 62.5% and the secondary patency rate may be as low 
as 66.0% at 1 year after the creation of the fistula[11,19,20]. 
The 1-year primary patency rates of BC AVFs and forearm pros-
thetic arteriovenous grafts have been reported to range from 
70% to 84% and 62% to 87% respectively[12,21,25].  
In this study, the primary and secondary patency rates of RC 
AVFs are better than the rates listed in a recent meta-analysis 
of radial-cephalic patency and better than the patency rates 
for prosthetic arteriovenous grafts. The primary and secondary 
patency rates of BC AVFs are better than the patency rates of 
both BC AVFs and prosthetic grafts[11,12].  
The main reason for the failure of functional secondary RC 
AVFs in this study was multiple needle puncture site stenoses 
in the outflow vein. 
One of the most commonly performed alternative secondary 
fistulas is the prosthetic graft. This type of fistula results in high 
rates of infection, steal symptoms, high-output cardiac failure, 
aneurysm formation, and thrombosis[26,27].  
According to the Turkish Nephrology Society Registry, in 25.7% 
of the patients receiving the routine hemodialysis treatment 
for the first time, the initial intravenous route is the temporary 
(nontunneled) subclavian catheterization[28]. Subclavian vein 
occlusion or stenosis can occur in up to 50% in patients who 
have had an indwelling subclavian catheter[29].  Subclavian 
vein occlusion confirmed by venography, contributed to 2 AVF 
failures in this study. 
These data suggests that it is more vital to create a snuff-box 
fistula, if possible, for primary vascular access before construc-
tion of an RC AVF is attempted. By doing so, a long vein seg-
ment is well preserved for needling, and this segment also pre-
serves proximal vessels for further AVF creation. An RC AVF 
should be the secondary choice in 61% of patients undergoing 
creation of a secondary access after a snuff-box AVF. This op-
eration is often facilitated by the presence of arterialized vein 
segment. This type of secondary AVF is associated with better 
outcomes, although additional studies are required.
The limitations of our study were that there were no random-
ized trials in literature, from which conclusions could be drawn. 
For that reason, this paper is the only report analyzing the sec-
ondary vascular access procedures created after functional 
snuff-box fistulas. It is clear that well-planned randomized tri-
als are needed to provide additional information about access 
surgery.
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